![]() |
Welcome to Loot.co.za!
Sign in / Register |Wishlists & Gift Vouchers |Help | Advanced search
|
Your cart is empty |
||
|
Books > Medicine > Clinical & internal medicine > Endocrinology > Diabetes
This book is the result of the study of metabolic and hormonal disorders in patients suffering obesity and diabetes mellitus, focusing on mechanisms of formation of atherosclerotic changes in the myocardium and vessels in diabetes mellitus patient.
This book tackles the problem of overshoot and undershoot in blood glucose levels caused by delay in the effects of carbohydrate consumption and insulin administration. The ideas presented here will be very important in maintaining the welfare of insulin-dependent diabetics and avoiding the damaging effects of unpredicted swings in blood glucose - accurate prediction enables the implementation of counter-measures. The glucose prediction algorithms described are also a key and critical ingredient of automated insulin delivery systems, the so-called "artificial pancreas". The authors address the topic of blood-glucose prediction from medical, scientific and technological points of view. Simulation studies are utilized for complementary analysis but the primary focus of this book is on real applications, using clinical data from diabetic subjects. The text details the current state of the art by surveying prediction algorithms, and then moves beyond it with the most recent advances in data-based modeling of glucose metabolism. The topic of performance evaluation is discussed and the relationship of clinical and technological needs and goals examined with regard to their implications for medical devices employing prediction algorithms. Practical and theoretical questions associated with such devices and their solutions are highlighted. This book shows researchers interested in biomedical device technology and control researchers working with predictive algorithms how incorporation of predictive algorithms into the next generation of portable glucose measurement can make treatment of diabetes safer and more efficient.
The Carbs & Cals Flashcards are a visual guide to counting carbs, calories and other nutrients in a range of popular food and drinks. Each of the 64 large, durable cards displays a food photo and portion weight. The reverse of the card shows the same photo with its nutritional information. NEW FEATURE for this edition: The amount of carbs are also displayed as blood glucose icons, to visually show the possible effect of each portion on blood glucose levels. Carbs & Cals Flashcards are perfect for diabetes, weight loss and portion control, and can be used in a variety of ways at home or in a clinical setting. Use alongside the Carbs & Cals PACK 1 and WORLD FOODS flashcard sets, to make a bumper pack of 192 unique flashcards!
Few diabetes books focus specifically on the day-to-day issues facing people who use insulin. Diabetes educator Gary Scheiner provides the tools to 'think like a pancreas' -- to successfully master the art and science of matching insulin to the body's ever-changing needs. Comprehensive, free of medical jargon, and packed with useful information not readily available elsewhere, such as: day-to-day blood glucose control and monitoring designing an insulin program to best match your lifestyleup-to date medication and technologynew insulin formulations and combinationsand moreWith detailed information on new medications and technologies -- both apps and devices -- surrounding insulin, as well as new injection devices, and dietary recommendations, Think Like a Pancreas is the insulin users go-to guide.
There is a world-wide epidemic on obesity. This epidemic is driving the immense proportions of Type 2 diabetes across the globe. While there are numerous therapies for treating Type 2 diabetes, the most effective therapy is prevention. Prevention of Type 2 diabetes can be achieved properly by simultaneous prevention of obesity. Prediabetes, or metabolic syndrome, is the period between simple obesity and diabetes, and this critical period needs to be identified in a more consistent and systematic manner by clinicians worldwide. Clinical trials have indicated that diabetes prevention can be achieved by lifestyle changes and also by certain medications, though none are yet approved for use in prevention. On the other hand, there are funding agencies such as the NIH, CDC, and State Institutions that are interested in studying the prevention paradigms in different communities and ethnic minorities who are most prone to this epidemic. For these reasons, this title by renowned physician-scientist Derek LeRoith is both timely and vitally important for academic physicians, practitioners, allied health care providers, analysts, community activists, and all others interested in this increasing epidemic. This book provides a unique and comprehensive synthesis of the prevention and early diagnosis of Type 2 Diabetes, focusing on identifying risk factors and then moving into topics that address how to prevent their progression to full-blown diabetes. The difficult task of changing patients' behavior is given special emphasis. The chapters in this practical volume are written by a wide range of international experts, reflecting the editor's distinguished, internationally renowned career. The volume is organized in eight sections: an introduction to the overall issue of prevention, definitions of values based on ADA guidelines, pathophysiology, discussion of a range of interventional trials regarding prevention, and an overview of state-of-the-art clinical management approaches. Comprehensive and timely, Prevention of Type 2 Diabetes: From Science to Therapy is an essential reference for those treating and researching Type 2 Diabetes.
The chapters of this book report cutting-edge research on molecular events in adiposity and type 2 diabetes, thus opening the way for innovative drug-based therapeutic strategies. It addresses all those who wish to keep in touch with recent developments in the field.
Diabetes type 2 - which results from insensitivity to insulin - and its precursor, metabolic syndrome, are reaching epidemic proportions yet if the root causes can be addressed the condition can be both prevented and reversed. Diabetes type 1 (autoimmune - arising from insufficient insulin) is caused by other factors (primary risk factors are dairy products, vitamin D deficiency and vaccines) but is also more prevalent today than ever before. Dr Myhill has long experience of helping her patients overcome diabetes and related problems of uncontrolled blood sugar and low energy; this informs her account of how and why burning fat rather than carbs is healthier, more natural and more efficient, and how the necessary 'metabolic flexibility' can be achieved. With the support of her co-author Craig Robinson, she also addresses the many other risk factors for diabetes, including environmental toxins, drugs (prescribed, over-the-counter and illegal), medical conditions and poor lifestyle choices, and how the multiple health problems that follow from poorly controlled blood sugar levels can be avoided.
From the pioneer of diabetes reversal and creator of the 'Newcastle
Diet'
This comprehensive volume discusses in vitro laboratory development of insulin-producing cells. It encompasses multiple aspects of islet biology-from embryonic development and stem cell differentiation to clinical studies in islet transplantation, regulation of islet beta-cell regeneration, pancreatic progenitors, mathematical modelling of islet development, epigenetic regulation, and much more. The chapter authors represent leading laboratories from around the world who contribute their international perspectives and global expertise. Collectively, they provide the reader with a concise yet detailed knowledge of processes and current developments in islet regenerative biology. Pancreatic Islet Biology, part of the Stem Cell Biology and Regenerative Medicine series, is essential reading for researchers and clinicians in stem cells or endocrinology, especially those focusing on diabetes.
Diabetes and its complications take the lives of over 3.2 million people worldwide every year. Thousands of people have succeeded in reducing their risk by using the first edition of "The Joslin Guide to Diabetes". Reflecting the vast range of new research and treatment options that have emerged in the ten years since the bestselling first edition of "The Joslin Guide to Diabetes" was published, this timely and authoritative second edition is far and away the most complete and up-to-date guide to diabetes self-care available anywhere. Drawing on the expertise of a team of internationally recognized experts, the authors address every important issue people face in diabetes management. Written in straightforward, easy-to-understand language and featuring numerous charts, the book covers how to develop a workable meal plan, how and when to monitor and treat blood glucose levels, how to administer insulin, the wide range of oral medications, the importance of physical activity in managing diabetes, strategies to reduce the risk of complications, and other vital information.
Darwinian medicine looks at the ecological and evolutionary roots of disease. A disease is an interaction between a genome and its biotic or abiotic environment and therefore a disease is essentially an ecological process. Good understanding of ecology and a Darwinian way of thinking can give us novel and useful perspectives on health and disease. If we understand the disease process better, we can certainly prevent, control as well as treat diseases in a better way. Although the thought that the origins of obesity and type 2 diabetes (T2D) might lie in our hunter gatherer adaptations is not new, research over the last decade makes us rethink many of the classical concepts. Brain and behavior is increasingly being recognized as central to all the endocrine, metabolic and immunological changes that earmark type 2 diabetes and other metabolic syndrome disorders. A major change in paradigm appears to be on the horizon and the proposed book intends to speed up the paradigm shift by raising important questions, pointing out flaws and inadequacies in the prevalent paradigm and stimulating radical rethinking which would redirect and refine the line of research as well as bring some fundamental changes in drug discovery and clinical practice.
Diabetes mellitus is a major public health problem affecting over 415 million people in the world. Extensive research over the decades and the recent discovery of new medicines have revolutionized our understanding and treatment of both type 2 diabetes and type 1 diabetes mellitus. This book contains selected topics that describe recent advances in research, and state of the art treatment of the two types of diabetes mellitus and their complications. The topics encompass epidemiology and pathogenesis of diabetes, clinical features, diagnosis and treatment of diabetes and related complications. The chapters contain essential background materials, as well as recent advances in researches in different aspects of diabetes mellitus. The books is expected to be useful for researchers, research students, as well as for the clinicians engaged in diabetes care and diabetes research.
In this updated edition, leading medical specialists critically review for the general practitioner the latest techniques for the clinical management of diabetic neuropathy. The contributors focus on the practical aspects of diabetic neuropathy and describe in detail the treatments that are currently available or expected to become available in the near future. They also include concise discussions of the pathogenesis of diabetic neuropathy.
This book comprehensively describes the association between metabolic syndrome and pancreatic cancer progression, and the mechanism of action and target definition with a view to drug discovery. Metabolic syndrome, which includes adnominal obesity, hypertension, dyslipidemia, and hyperglycemia, has recently been shown to play an important role in the etiology and progression of various cancers. Further, obesity and diabetes have been associated with an increased incidence of gastric cancers. The book reviews the key biological mechanisms underlying the association between metabolic dysregulation, including obesity-associated enhancement of growth factor signaling, inflammation, and perturbation in pancreatic cancer cell growth and metastasis. It also illustrates the role of the inflammatory signaling pathway in metabolic diseases as well as tumor growth and explores the potential of these pathways as the rational targets for pancreatic cancer therapy. Lastly, the book offers a comprehensive description of the challenges associated with diabetes and pancreatic cancer therapy.
This book presents essential information on biomechanical features of the diabetic foot, which could help to minimize the risk of future diabetic foot problems. India has recently been classified as the 'diabetic capital' of the world. Type 2 diabetes mellitus has become a serious concern for Indian society, where the prevalence rate is increasing exponentially. Similarly, the comorbidities and foot complications of type 2 diabetes mellitus are worsening day by day. Of all complications, diabetes peripheral neuropathy is the most common, and leads to foot deformities, pain, altered sensation, loss of foot arch, etc. The ultimate fate can even be gangrene and amputation. Accordingly, foot complications of diabetes represent a pressing medical issue. Sharing insights into diabetic foot syndrome, its causative factors, prevention and management, this book offers a valuable resource for medical and paramedical students, researchers, podiatrists, surgeons, and physicians alike.
While Type 1 diabetes is still predominantly a hospital-based specialty, increasing numbers of patients are being supervised in primary care. This book emphasises both the unique nature of Type 1 diabetes and its fundamental differences from Type 2 diabetes (at least in its 'classic' form), and also draws together the common threads of management - especially in the diagnosis and treatment of microvascular complications, its common coexistence with the insulin resistance syndrome, and the importance of late-onset Type 1 diabetes in older patients. This highly practical volume in the Oxford Diabetes Library is intended for all advanced practitioners in primary and secondary care. Wherever it is available, the limited RCT evidence base for practice in Type 1 diabetes is quoted and put into a practical context.
Now in its second edition, this comprehensive handbook provides a state-of-the-art overview of recent advances in drug and non-drug therapies for obesity and diabetes. It also addresses major comorbidities, covering topics such as, cardiovascular diseases, renal and neuropsychiatric disorders, appetite control and micro RNAs. Special attention is also devoted to pediatric care, including the latest recommendations for therapy and prevention. Obesity and type 2 diabetes are among the top global health-care budget concerns worldwide and impact professional practice at all levels: in hospitals, clinics and physicians' offices alike. They prominently feature in headlines, and virtually no family, community or country is exempt from their protean, deleterious consequences. Furthermore, given the multiple intersections in their pathways, they often go hand in hand. The good news is that scientific advances in all fields, including genomics, metabolomics, lipidomics and microbiomics, are increasing our understanding of these two disease areas. At the same time, artificial intelligence, machine learning, mobile health and advanced implantable and external devices are rendering prevention and management more available, safe and cost-effective. In addition, bariatric and metabolic surgery has evolved from a niche specialty to an officially endorsed option for several modalities of obesity and diabetes. This book presents the latest lifestyle, pharmacological, surgical and non-surgical treatment options, including endoscopic intervention and cell therapy. Objectively reviewing natural and artificial sweeteners and critically examining issues such as public health initiatives, government mandated taxes for unhealthy foods and environmental planning, no stone is left unturned in gathering the latest practical information. As such, the book will appeal to seasoned specialists, as well as students and healthcare professionals in training.
Sirtuin Biology in Cancer and Metabolic Disease: Cellular Pathways for Clinical Discovery offers a compelling and thought-provoking perspective for the examination of the intriguing biology of sirtuins that ties cancer and metabolic disease together and provides a critical platform for the development of sirtuin-based novel therapeutic strategies to effectively treat cancer and metabolic disorders with precision in order to minimize any potentially detrimental clinical outcomes. An exciting prospect for the development of innovative therapeutics for cancer and metabolic disorders involves sirtuins. Sirtuins are histone deacetylases that have an intricate role in the onset and development of cancer and metabolic disease. Implementing a translational medicine format, this innovative reference highlights the ability of sirtuins to oversee critical pathways that involve stem cell maintenance, cellular proliferation, metabolic homeostasis, apoptosis, and autophagy that can impact cellular dysfunction and unchecked cellular growth that can occur during cancer and metabolic disease. Each chapter offers an intuitive perspective of advances on the application of sirtuin pathways for cancer and metabolic disease that will be become a "go-to" resource for a broad audience of scientists, physicians, pharmaceutical industry experts, nutritionists, and students.
he therapies outlined in this book provide safe and effective option for diabetics. Numerous vitamins, minerals, herbs, and other nutrients can help prevent or control diabetes. This book examines clinically proven dietary strategies, supplements, and lifestyle changes.
Type-2 diabetes is fast reaching epidemic proportions in the U.S. More that 17 million Americans have been diagnosed with the disorder and an estimated 16 million more are living with the disease, but have yet to be diagnosed. Dr. Shallenberger presents his revolutionary approach to treating Type-2 Diabetes and documents his extensive research, which shows that the root of diabetes is a decrease in energy production and fat metabolism. He describes his patented Bio-Energy Test for measuring energy production, an integral part of diagnosing and treating diabetes. At the core of his treatment protocol is his unique perspective on nutritional guidelines for diabetics for optimal energy production. In fact he explains why the American Diabetes Association's dietary guidelines are nothing more than a recipe for keeping the disease.
There is an epidemic of diabetes and the problem is only getting worse. More than 220 million people worldwide have diabetes, and over 3 million people die from the consequences of the disease each yer. Diabetes deaths will double by the year 2030. Fortunately, here is an answer. This book can help the majority of diabetics come off all or most medications by changing their lifestyle, eating a healthier diet, starting to exercise, and taking nutraceuticals.
This book is the first of two volumes that offer a comprehensive, up-to-date account of current knowledge regarding high-density lipoprotein (HDL), the changes that occur in HDL under different conditions, the clinical applications of HDL, and means of enhancing HDL functionality. HDL comprises a diverse group of lipoproteins and its composition and metabolism are dynamic. In this volume, the focus is on the changes observed in HDL under different health statuses, with particular attention to the functional and structural correlations of HDL and apolipoprotein A-1. The impacts of a wide variety of factors on HDL are examined in depth, covering, for example, diet, exercise, smoking, age, diverse diseases, and different forms of environmental pollution. It has long been known that HDL has anti-atherosclerotic and antidiabetic properties, and more recently its anti-aging activities have been recognized. These benefits of HDL are highly dependent on its lipids, proteins, apolipoproteins, and enzymes, and specifically their composition and ratios. In documenting the latest knowledge in this field, this volume will be of interest to both researchers and clinicians.
Diabetes: Oxidative Stress and Dietary Antioxidants, Second Edition, builds on the success of the first edition, covering updated research on the science of oxidative stress in diabetes and the potentially therapeutic usage of natural antioxidants in the diet and food matrix. The processes within the science of oxidative stress are not described in isolation, but rather in concert with other processes, such as apoptosis, cell signaling and receptor mediated responses. This approach recognizes that diseases are often multifactorial and oxidative stress is a single component of this. Since the publication of the first edition, the science of oxidative stress and free radical biology continues to rapidly advance with thousands of the research articles on the topic. New sections in this update cover the role of dietary advanced glycation end products (AGEs) in causing OS in diabetes, oxidative stress and diabetes-induced bone metabolism, and oxidative stress and diabetic foot ulcer.
In this pocket version of his bestselling Life Without Diabetes, Professor Roy Taylor offers a brilliantly concise explanation of what happens to us when we get type 2 and how we can escape it. Taylor's research has demonstrated that type 2 is caused by just one factor - too much internal fat in the liver and pancreas - and that to reverse it you need to strip this harmful internal fat out with rapid weight loss. In simple, accessible language, Taylor takes you through the three steps of his clinically proven Newcastle weight loss plan and shows how to incorporate the programme into your life. Complete with FAQs and inspirational tips from his trial participants, this is an essential read for anyone who has been given a diagnosis of type 2 diabetes or pre-diabetes and wants to understand their condition and transform their outcomes. |
You may like...
Carbs & Cals: Carb & Calorie Counter…
Chris Cheyette, Yello Balolia
Paperback
(3)R541 Discovery Miles 5 410
Sweet-Ass Journal to Optimize Your…
Heath Armstrong, Caitlin Grenier
Hardcover
Emerging Nanomedicines for Diabetes…
Michael K. Danquah, Jaison Jeevanandam
Paperback
R3,714
Discovery Miles 37 140
The Best Life Guide to Managing Diabetes…
Bob Greene, John J. Merendino Jr., M.D., …
Paperback
Controversies In Diabetic Neuropathy…
Nigel Calcutt, Paul Fernyhough
Hardcover
R4,522
Discovery Miles 45 220
Carbs & Cals Gestational Diabetes - 100…
Chris Cheyette, Yello Balolia
Paperback
(1)R440 Discovery Miles 4 400
Carbs & Cals Very Low Calorie Recipes…
Chris Cheyette, Yello Balolia
Paperback
R376
Discovery Miles 3 760
|